Preoperative Hyperlactatemia Predicts Mortality in Acute Stanford Type A Dissection: A 16-Year-Period, Single-Center, Retrospective Study
<b>Background:</b> Acute Stanford Type A aortic dissection (ATAAD) is a devastating disease requiring immediate surgery. A life-threatening complication hereby represents organ malperfusion. Lactate is a product of anaerobic glycolysis indicating organ malperfusion. The current study analyzes preoperative lactate acidosis as a surrogate marker for patients' outcome after surgery for ATAAD over a 15-year period. <b>Methods:</b> In a single-center setting, 306 consecutive patients, who underwent surgery for ATAAD between 2000 and 2016, were analyzed retrospectively. Serum lactate measurements were taken before surgery. To define a simple cut-point of the predictor lactate, the maximally selected rank statistics method was used. <b>Results:</b> Median survival was 9.3 ± 0.5 and CI 95% [8.3-10.2] years. Mean lactate levels were 1.95 mmol/L ± 2.19 mmol/L (range: 0.15-19.27 mmol/L). Patients with a lactate level > 3.71 mmol/L had a higher 30-day mortality compared to patients with lactate levels ≤ 3.71 mmol/L (51.5% versus 18.7%). In a logistic regression model adjusted for clinical baseline characteristics at index procedure, lactate levels > 3.71 mmol/L reached the highest Odd for 30-day mortality of all tested risk factors (OR = 7.292; CI95% [3.029-17.555]; <i>p</i> < 0.0001). Analyzing the overall mortality, the early effect of lactate level > 3.71 mmol/L persists. The HRs for overall mortality, however, revealed substantially lower effects (HR = 2.772; (CI95% [1.689-4.550]; <i>p</i> < 0.0001). In patients who survived the first 30 days postoperatively, no clinical parameter other than age had a significant impact on survival, including lactate > 3.71 mmol/L (<i>p</i> = 0.494). <b>Conclusions:</b> In patients with ATAAD, preoperative lactate represents an easily obtainable surrogate marker for organ malperfusion. A preoperative lactate level > 3.71 mmol/L depicts the strongest marker for early mortality after surgery.
Authors
- Nazan Puluca (ORCID: https://orcid.org/0000-0003-2605-1247)
- Birgit Waschulzik (ORCID: https://orcid.org/0000-0001-6365-7972)
- Wolfgang Köenig (ORCID: https://orcid.org/0000-0002-2064-9603)
- Johannes Boehm (ORCID: https://orcid.org/0000-0001-5191-0360)
- Keti Vitanova (ORCID: https://orcid.org/0000-0002-8308-7679)
- Markus Krane (ORCID: https://orcid.org/0000-0002-5466-9290)
- Gunther Wiesner (ORCID: https://orcid.org/0000-0002-5607-1786)
Institutions
- German Centre for Cardiovascular Research (DE)
- Deutsches Herzzentrum München (DE)
- Technical University of Munich (DE)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-05-22
- DOI
- https://doi.org/10.3390/jcm14113619
- Primary Topic
- Aortic Disease and Treatment Approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00